EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PLGA-Based In Situ-Forming Implants, a Quality by Design Perspective

Nayelli Campos-Morales iD, Luz Graciela Cervantes-Pérez iD, Alicia Sánchez-Mendoza, María Sánchez-Aguilar iD, José Juan Escobar-Chávez iD, Lizbeth Martínez-Acevedo, Moises Job Galindo-Pérez, Jorge Esteban Miranda-Calderon

Pharmaceutics · 12.03.2026 · 18 (3) · 351

DOI: 10.3390/pharmaceutics18030351 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 12.03.2026. Verfasst von Nayelli Campos-Morales und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ciencias Farmacéuticas, Universidad Autónoma Metropolitana, Unidad Xochimilco, Calzada del Hueso 1100, Colonia Villa Quietud, Alcaldía Coyoacán, Mexi…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In situ-forming implants (ISFIs) based on poly(lactic-co-glycolic acid) (PLGA) offer a promising platform for long-acting parenteral drug delivery, enabling minimally invasive administration without surgical implantation. However, the development and clinical translation of PLGA-based ISFIs are hindered by formulation complexity, sensitivity to aterial variability, and limited predictability of drug release, particularly during early implant formation. Although previous reviews have described formulation components and release mechanisms, a comprehensive integration of Quality by Design (QbD) principles with a focus on risk prioritization remains absent. This review examines the application of QbD to solvent-exchange PLGA-based ISFIs, with an emphasis on identifying critical material attributes (CMAs) governing implant formation, burst release, and long-term release performance. Risk-based prioritization of CMAs and the role of design of experiments are systematically discussed. Special attention is given to burst release as a major CMA affecting safety, efficacy, and translational robustness. The evidence indicates that formulation-driven CMAs, such as polymer physicochemical properties, drug characteristics, and solvent selection, exert a greater influence on ISFI performance than process-related parameters. This review provides a structured perspective to support rational formulation design, improved reproducibility, and enhanced clinical translation of PLGA-based ISFI systems.

Schlagwörter

Stichwörter der Autor:innen

QbDimplantinjectable

Autor:innen und Institutionen

  • Ciencias Farmacéuticas, Universidad Autónoma Metropolitana, Unidad Xochimilco, Calzada del Hueso 1100, Colonia Villa Quietud, Alcaldía Coyoacán, Mexico City C.P. 04960, Mexico.
  • Instituto Nacional de Cardiología, Juan Badiano 1, Belisario Domínguez Secc 16, Tlalpan, Mexico City C.P. 14080, Mexico.
  • Unidad de Investigación Multidisciplinaria-L 12, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Carretera Cuautitlán-Teoloyucan, Km 2.5 San Sebastián Xhala, Cuautitlán Izcalli C.P.…
  • Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana, Unidad Xochimilco, Calzada del Hueso 1100, Colonia Villa Quietud, Alcaldía Coyoacán, Mexico City C.P. 04960, Mexico.
  • Departamento de Procesos y Tecnología, Universidad Autónoma Metropolitana, Unidad Cuajimalpa, Av. Vasco de Quiroga 4871, Santa Fe Cuajimalpa, Mexico City C.P. 05348, Mexico.

ORCID-Profile: Nayelli Campos-Morales, Luz Graciela Cervantes-Pérez, María Sánchez-Aguilar, José Juan Escobar-Chávez

Zitieren

APA

Campos-Morales, N., Cervantes-Pérez, L. G., Sánchez-Mendoza, A., Sánchez-Aguilar, M., Escobar-Chávez, J. J., Martínez-Acevedo, L., Galindo-Pérez, M. J., & Miranda-Calderon, J. E. (2026). PLGA-Based In Situ-Forming Implants, a Quality by Design Perspective. Pharmaceutics, 18(3), 351. https://doi.org/10.3390/pharmaceutics18030351

Vancouver

Campos-Morales N, Cervantes-Pérez LG, Sánchez-Mendoza A, Sánchez-Aguilar M, Escobar-Chávez JJ, Martínez-Acevedo L, et al. PLGA-Based In Situ-Forming Implants, a Quality by Design Perspective. Pharmaceutics. 2026;18(3):351. doi:10.3390/pharmaceutics18030351

BibTeX
@article{CamposMorales2026,
  author = {Campos-Morales, Nayelli and Cervantes-Pérez, Luz Graciela and Sánchez-Mendoza, Alicia and Sánchez-Aguilar, María and Escobar-Chávez, José Juan and Martínez-Acevedo, Lizbeth and Galindo-Pérez, Moises Job and Miranda-Calderon, Jorge Esteban},
  title = {PLGA-Based In Situ-Forming Implants, a Quality by Design Perspective},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {351},
  doi = {10.3390/pharmaceutics18030351}
}
Kostenlos starten →